Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles-Reference-Cited by-同舟云学术

Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles

Published:2020-08 Issue: Volume:58 Page:101790
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Paul Ankita,Yadav Khushwant S.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference111 articles.

1. The role of extracellular vesicles in neurodegenerative diseases;Quek;Biochem. Biophys. Res. Commun.,2017

2. Machine learning and similarity network approaches to support automatic classification of Parkinson's diseases using accelerometer-based gait analysis;Rastegari,2019

3. Recent prospective of surface engineered nanoparticles in the management of neurodegenerative disorders;Singh;Artif. Cells Nanomed. Biotechnol.,2016

4. Genetics of Parkinson disease;Pankratz;Genet. Med.,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides;Current Protein & Peptide Science;2024-09

2. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease;Movement Disorders;2024-07-30

3. Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review;Current Drug Delivery;2024-06

4. Evaluating the Neuroprotective Potential of Novel Benzodioxole Derivatives in Parkinson’s Disease via AMPA Receptor Modulation;ACS Chemical Neuroscience;2024-05-15

5. A recent update on drugs and alternative approaches for parkinsonism;Neuropeptides;2024-04